These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34504981)

  • 1. Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.
    Chakraborty D; Sheth JU; Boral S; Sinha TK
    Am J Ophthalmol Case Rep; 2021 Dec; 24():101197. PubMed ID: 34504981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series.
    Chakraborty D; Mondal S; Boral S; Das A
    Case Rep Ophthalmol; 2022; 13(3):921-928. PubMed ID: 36466059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Experience With Brolucizumab 6 mg for Diabetic Macular Edema.
    Bragança F; Ferreira A; Leite J; Coelho J; Borges T; Caiado F; Correia N; Beirão J; Menéres P; Pessoa B
    Cureus; 2024 Jan; 16(1):e52176. PubMed ID: 38344619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series.
    Chakraborty D; Sheth JU; Mondal S; Boral S
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101390. PubMed ID: 35198814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema.
    Rübsam A; Hössl L; Rau S; Böker A; Zeitz O; Joussen AM
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38542043
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral effect following off label unilateral intravitreal brolucizumab injection in patient with pseudophakic cystoid macular edema.
    Kelkar A; Bolisetty M; Jadhav A
    Eur J Ophthalmol; 2024 Mar; 34(2):NP48-NP51. PubMed ID: 37644807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy.
    Hsu AY; Lin CY; Lin CJ; Lai CT; Hsia NY; Lin JM; Tien PT; Meng PP; Ku WN; Chen WL; Tsai YY
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556905
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab.
    Corradetti G; Corvi F; Juhn A; Sadda SR
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100981. PubMed ID: 33145457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration.
    Enríquez AB; Baumal CR; Crane AM; Witkin AJ; Lally DR; Liang MC; Enríquez JR; Eichenbaum DA
    JAMA Ophthalmol; 2021 Apr; 139(4):441-448. PubMed ID: 33630045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.
    Singh RP; Barakat MR; Ip MS; Wykoff CC; Eichenbaum DA; Joshi S; Warrow D; Sheth VS; Stefanickova J; Kim YS; He F; Cho GE; Wang Y; Emanuelli A
    JAMA Ophthalmol; 2023 Dec; 141(12):1152-1160. PubMed ID: 37971723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration.
    Abdin AD; Aljundi W; El Jawhari K; Suffo S; Weinstein I; Seitz B
    Front Pharmacol; 2022; 13():860784. PubMed ID: 35721125
    [No Abstract]   [Full Text] [Related]  

  • 13. Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema.
    Chakraborty S; Sheth JU
    Case Rep Ophthalmol Med; 2022; 2022():3755249. PubMed ID: 35127189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of extra-large pigment epithelial detachment to intravitreal brolucizumab injection.
    Chakraborty S; Umed Sheth J
    Am J Ophthalmol Case Rep; 2023 Jun; 30():101829. PubMed ID: 37252048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy.
    Murray JE; Gold AS; Latiff A; Murray TG
    Clin Ophthalmol; 2021; 15():4731-4738. PubMed ID: 34983996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].
    Book M; Ziegler M; Rothaus K; Faatz H; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Ophthalmologe; 2022 Mar; 119(3):258-264. PubMed ID: 34351479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting.
    Maggio E; Sartore M; Attanasio M; Maraone G; Guerriero M; Polito A; Pertile G
    Am J Ophthalmol; 2018 Nov; 195():209-222. PubMed ID: 30098350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
    Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA
    Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
    Dugel PU; Jaffe GJ; Sallstig P; Warburton J; Weichselberger A; Wieland M; Singerman L
    Ophthalmology; 2017 Sep; 124(9):1296-1304. PubMed ID: 28551167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
    Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME;
    Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.